The National Cord Blood Inventory (NCBI) is included in the Stem Cell Therapeutic and Research Act of 2005, Public Law 109-129, and reauthorized by Congress in 2010, 2015, and 2021 (P.L. 111-264, P.L. 114-104, and P.L. 117-15).
There are 9 cord blood banks that have received an NCBI contract to help add at least 150,000 new cord blood units. These contracted banks:
- Encourage more cord blood donations, with special emphasis on parents of racially or ethnically diverse backgrounds.
- Collect and store cord blood units and make them available through the CWBYCTP.
- Ensure the cord blood units are of high-quality and meet specified criteria such as having a certain number of blood-forming cells. Cord blood units that do not meet these criteria may be available for research studies intended to improve patient outcomes.
- Protect the rights of donating mothers by obtaining consent to donate from the mother and maintaining confidentiality of the mother and baby.
- Provide cord blood unit data to the CWBYCTP Stem Cell Therapeutic Outcomes Database contractor.
NCBI Program Contractors
The healthy blood-forming cells for a transplant can come from the marrow of a donor or umbilical cord blood that is collected after a baby is born. The blood-forming cells from cord blood have unique qualities that can help some patients who would otherwise be unable to have a potentially life-saving transplant. Cord blood banks collect and store cord blood to make the cells available to patients in need. NCBI contracted cord blood banks receive funding from the Health Resources and Services Administration (HRSA) to reach the goal of collecting and storing at least 150,000 cord blood units.
Some cord blood units collected by the contractors may be available for research studies. Research studies are intended to help improve patient outcomes.
The following cord blood banks are currently under contract with HRSA and collecting cord blood units for the NCBI: